The COVID-19 pandemic is anticipated to have a significant effect on the disposable syringe business in the U.S. The SARS-CoV-2 pandemic has caused a considerable increase in demand for hospital supplies, emergency supplies, medical disposables, and medications. Due to COVID-19, there has been an increase in COVID-19 vaccine production, which has led to an increase in demand for disposable syringes made in the U.S. In January 2020, in the U.S. alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. Therefore, the COVID-19 outbreak has immensely impacted medical disposables market and is considered to be a highly effective driver for U.S. disposable syringes market.
Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.
U.S. Disposable Syringes Market Report Highlights
- On the basis of product, disposable syringes market has been segmented into conventional and safety syringes. Safety syringes segment held the largest share of around 64.5% in 2023 and is anticipated to witness a significant growth over the forecast period, owing to the various advantages, such as safety and easy to use, associated with this product.
- On the basis of application, the therapeutic injection segment held the largest market share of around 86.2% in 2023, owing to the increasing awareness towards blood donation and high prevalence of diseases such as HIV infection, tuberculosis malaria, and dengue in the country.
- California disposable syringes market is expected to witness the fastest growth rate over the forecast period. Factors that can be attributed to market growth include growing geriatric population, increasing number of surgeries, and rising expenditure on healthcare.
Table of Contents
Companies Mentioned
- Medtronic
- Nipro Corporation
- Fresenius Kabi Ag
- Baxter International, Inc.
- Braun Medical, Inc.
- Becton, Dickinson And Company (Bd)
- Flextronics International Vita Needle Company
- Terumo Corporation
- Novo Nordisk
- Ultimed, Inc.
- Henke-sass, Wolf
- Retractable Technologies, Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 110 |
Published | May 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 2.55 Billion |
Forecasted Market Value ( USD | $ 3.69 Billion |
Compound Annual Growth Rate | 5.5% |
Regions Covered | United States |
No. of Companies Mentioned | 12 |